This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Retrophin, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kayvon Emile Sharghi: Innovator in Autism Treatment
Introduction
Kayvon Emile Sharghi is a notable inventor based in Chevy Chase, MD (US). He has made significant contributions to the field of autism treatment through his innovative research and patent.
Latest Patents
Sharghi holds a patent for "Intranasal carbetocin formulations and methods for the treatment of autism." This patent focuses on methods and compositions that utilize oxytocin or its analogs, such as carbetocin, to prevent and treat autism spectrum disorders. The methods are designed to address various symptoms, including social withdrawal, anxiety, and communication difficulties. His work aims to provide more effective treatment tools for individuals affected by autism spectrum disorders.
Career Highlights
Sharghi is associated with Retrophin, Inc., where he continues to advance his research in the field of autism treatment. His dedication to improving therapeutic options for autism has positioned him as a key figure in this area of study.
Collaborations
Some of his notable coworkers include Alexis Kays Leonard and Joshua Sestak, who contribute to the collaborative efforts in research and development at Retrophin, Inc.
Conclusion
Kayvon Emile Sharghi's innovative work in developing treatments for autism spectrum disorders highlights his commitment to improving the lives of those affected by these conditions. His contributions through patents and collaboration with colleagues underscore the importance of continued research in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile